Closed Loop Medicine partners with US pharma companies to develop precision dosing solutions for GLP-1 and direct oral anticoagulants
Closed Loop Medicine partners with US pharma companies to develop precision dosing solutions for GLP-1 and direct oral anticoagulants
03/25/25, 1:20 AM
Location
cambridgeType
partnership
Closed Loop Medicine (CLM) has expanded its US patent portfolio to cover advancements in GLP-1 medicines and direct oral anticoagulants, enabling the development of personalised treatments to address weight loss unpredictability and adverse effects in weight management programmes. The company's AI-powered precision dosing solutions aim to improve safety and efficacy in stroke prevention and other cardiovascular conditions while reinforcing its ability to deliver smarter, AI-enabled pharmacometric dosing solutions.
Company Info
Location
cambridge, massachusetts, united states
Additional Info
Closed Loop Medicine is a TechBio company developing prescription combination drug + software products, to bring forward the promise of precision medicine.
The Company’s proprietary platform facilitates personalised drug dose optimisation, through integration of drugs and devices with patient-led digital experiences and closed loop models of care.